bnt162b2 Search Results


86
Pfizer Inc bnt162b2
Bnt162b2, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2/product/Pfizer Inc
Average 86 stars, based on 1 article reviews
bnt162b2 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
BioNTech mrna vaccines
Mrna Vaccines, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mrna vaccines/product/BioNTech
Average 90 stars, based on 1 article reviews
mrna vaccines - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
GenScript corporation bnt162b2
Patient characteristics
Bnt162b2, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2/product/GenScript corporation
Average 90 stars, based on 1 article reviews
bnt162b2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
EASDALE SEAFOODS LIMITED bnt162b2
Patient characteristics
Bnt162b2, supplied by EASDALE SEAFOODS LIMITED, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2/product/EASDALE SEAFOODS LIMITED
Average 90 stars, based on 1 article reviews
bnt162b2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
AstraZeneca ltd chadox1-s + bnt162b2
Patient characteristics
Chadox1 S + Bnt162b2, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chadox1-s + bnt162b2/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
chadox1-s + bnt162b2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
SYNLAB International GmbH bnt162b2 mrna covid-19 vaccine comirnaty
Patient characteristics
Bnt162b2 Mrna Covid 19 Vaccine Comirnaty, supplied by SYNLAB International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2 mrna covid-19 vaccine comirnaty/product/SYNLAB International GmbH
Average 90 stars, based on 1 article reviews
bnt162b2 mrna covid-19 vaccine comirnaty - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Makoto USA Inc bnt162b2 mrna vaccine
COVID-19 Related Articles (in Order of Number of Citations).
Bnt162b2 Mrna Vaccine, supplied by Makoto USA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2 mrna vaccine/product/Makoto USA Inc
Average 90 stars, based on 1 article reviews
bnt162b2 mrna vaccine - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Verlag GmbH bnt162b2
COVID-19 Related Articles (in Order of Number of Citations).
Bnt162b2, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
bnt162b2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
EUROIMMUN mrna1273 bnt162b2
Clinical studies evaluating the antibody response to a full course (two doses) of anti-SARS-CoV-2 vaccines in solid organ transplant recipients. Only reports that have been published in extenso in peer-reviewed scientific journals are cited.
Mrna1273 Bnt162b2, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mrna1273 bnt162b2/product/EUROIMMUN
Average 90 stars, based on 1 article reviews
mrna1273 bnt162b2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
LabCorp bnt 162b2 vaccine
Characteristics of the studies describing the effectiveness and safety of SARS‐CoV‐2 vaccines in inflammatory Bowel Disease (IBD) patients
Bnt 162b2 Vaccine, supplied by LabCorp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt 162b2 vaccine/product/LabCorp
Average 90 stars, based on 1 article reviews
bnt 162b2 vaccine - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
TriNetX Inc bnt162b2 vaccine
Characteristics of the studies describing the effectiveness and safety of SARS‐CoV‐2 vaccines in inflammatory Bowel Disease (IBD) patients
Bnt162b2 Vaccine, supplied by TriNetX Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2 vaccine/product/TriNetX Inc
Average 90 stars, based on 1 article reviews
bnt162b2 vaccine - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
HealthCore Inc ad26.cov2.s
Characteristics of the studies describing the effectiveness and safety of SARS‐CoV‐2 vaccines in inflammatory Bowel Disease (IBD) patients
Ad26.Cov2.S, supplied by HealthCore Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ad26.cov2.s/product/HealthCore Inc
Average 90 stars, based on 1 article reviews
ad26.cov2.s - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Patient characteristics

Journal: International Journal of Hematology

Article Title: Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma

doi: 10.1007/s12185-022-03300-4

Figure Lengend Snippet: Patient characteristics

Article Snippet: , Terpos [ ] , 37/0 , 1st V , BNT162b2 , 25% , ND , GenScript , NA , 2 , ND , 72% , ND.

Techniques: Biomarker Discovery

Comparison to other reports and Literature review

Journal: International Journal of Hematology

Article Title: Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma

doi: 10.1007/s12185-022-03300-4

Figure Lengend Snippet: Comparison to other reports and Literature review

Article Snippet: , Terpos [ ] , 37/0 , 1st V , BNT162b2 , 25% , ND , GenScript , NA , 2 , ND , 72% , ND.

Techniques: Comparison

COVID-19 Related Articles (in Order of Number of Citations).

Journal: Internal Medicine

Article Title: Internal Medicine Year in Review 2022

doi: 10.2169/internalmedicine.2266-23

Figure Lengend Snippet: COVID-19 Related Articles (in Order of Number of Citations).

Article Snippet: 11 , Antibody Responses to the BNT162b2 mRNA Vaccine in Healthcare Workers in a General Hospital in Japan: A Comparison of Two Assays for Anti-spike Protein Immunoglobulin G , Hibino Makoto, et al , 4 , 2022 , 61 , 6 , 811 , 819.

Techniques: Control, Comparison, Variant Assay, Infection

Clinical studies evaluating the antibody response to a full course (two doses) of anti-SARS-CoV-2 vaccines in solid organ transplant recipients. Only reports that have been published in extenso in peer-reviewed scientific journals are cited.

Journal: Digestive and Liver Disease

Article Title: Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients

doi: 10.1016/j.dld.2021.07.019

Figure Lengend Snippet: Clinical studies evaluating the antibody response to a full course (two doses) of anti-SARS-CoV-2 vaccines in solid organ transplant recipients. Only reports that have been published in extenso in peer-reviewed scientific journals are cited.

Article Snippet: Boyarsky et al. , SOT , 658 , - , - , mRNA1273 BNT162b2 , Euroimmun® Roche Elecsys® ——— 28 to 31 , Overall: 54% LT: 32% , • Younger age • Liver transplantation • Longer time since transplantation • Immunosuppression without mycophenolate • mRNA1273 vaccine.

Techniques: Vaccines, Transplantation Assay, Enzyme-linked Immunosorbent Assay

Characteristics of the studies describing the effectiveness and safety of SARS‐CoV‐2 vaccines in inflammatory Bowel Disease (IBD) patients

Journal: Alimentary Pharmacology & Therapeutics

Article Title: Effectiveness and safety of SARS‐CoV‐2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta‐analysis and meta‐regression

doi: 10.1111/apt.16913

Figure Lengend Snippet: Characteristics of the studies describing the effectiveness and safety of SARS‐CoV‐2 vaccines in inflammatory Bowel Disease (IBD) patients

Article Snippet: Ben Tov et al,2021 , Multicentre, retrospective cohort , Israel , Data from Maccabi Healthcare services between December 2020 and March 2021 including 12,231 IBD patients , Age ≥ 16 years with diagnosis of IBD based on the registry , BNT 162b2 Vaccine , Anti‐receptor binding domain IgG antibodies specific to SARS‐CoV‐2 using the LabCorp Cov2Quant IgG assay.

Techniques: Vaccines, Biomarker Discovery, Binding Assay, Infection, Medications, Enzyme-linked Immunosorbent Assay

Studies describing seroconversion after SARS‐CoV‐2 vaccination in inflammatory Bowel Disease patients

Journal: Alimentary Pharmacology & Therapeutics

Article Title: Effectiveness and safety of SARS‐CoV‐2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta‐analysis and meta‐regression

doi: 10.1111/apt.16913

Figure Lengend Snippet: Studies describing seroconversion after SARS‐CoV‐2 vaccination in inflammatory Bowel Disease patients

Article Snippet: Ben Tov et al,2021 , Multicentre, retrospective cohort , Israel , Data from Maccabi Healthcare services between December 2020 and March 2021 including 12,231 IBD patients , Age ≥ 16 years with diagnosis of IBD based on the registry , BNT 162b2 Vaccine , Anti‐receptor binding domain IgG antibodies specific to SARS‐CoV‐2 using the LabCorp Cov2Quant IgG assay.

Techniques: Medications, Vaccines

Outcomes of studies describing breakthrough CoV‐19 infection in vaccinated inflammatory Bowel Disease (IBD) patients

Journal: Alimentary Pharmacology & Therapeutics

Article Title: Effectiveness and safety of SARS‐CoV‐2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta‐analysis and meta‐regression

doi: 10.1111/apt.16913

Figure Lengend Snippet: Outcomes of studies describing breakthrough CoV‐19 infection in vaccinated inflammatory Bowel Disease (IBD) patients

Article Snippet: Ben Tov et al,2021 , Multicentre, retrospective cohort , Israel , Data from Maccabi Healthcare services between December 2020 and March 2021 including 12,231 IBD patients , Age ≥ 16 years with diagnosis of IBD based on the registry , BNT 162b2 Vaccine , Anti‐receptor binding domain IgG antibodies specific to SARS‐CoV‐2 using the LabCorp Cov2Quant IgG assay.

Techniques: Infection, Comparison, Control